Last updated on February 2019

Chart Review of Repatha in Subjects With Hyperlipidaemia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Hypercholesterolemia
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

Adults (>18 years) Provided informed consent Initiated on Repatha at physician's discretion, after 1st August 2015 Received at least one dose of Repatha

Exclusion Criteria:

Enrolled in an interventional study of PCSK9 inhibitor within 12 weeks prior to initiation of Repatha Received commercially available PCSK9 inhibitor within 12 weeks prior to initiation of Repatha

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.